Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to 0.27.

  • China Pharma Holdings' Asset Utilization Ratio fell 3147.4% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year decrease of 3147.4%. This contributed to the annual value of 0.29 for FY2024, which is 2943.83% down from last year.
  • Latest data reveals that China Pharma Holdings reported Asset Utilization Ratio of 0.27 as of Q3 2025, which was down 3147.4% from 0.31 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Asset Utilization Ratio registered a high of 0.56 during Q1 2021, and its lowest value of 0.27 during Q3 2025.
  • In the last 5 years, China Pharma Holdings' Asset Utilization Ratio had a median value of 0.44 in 2023 and averaged 0.43.
  • In the last 5 years, China Pharma Holdings' Asset Utilization Ratio skyrocketed by 2806.62% in 2021 and then plummeted by 3147.4% in 2025.
  • Quarter analysis of 5 years shows China Pharma Holdings' Asset Utilization Ratio stood at 0.47 in 2021, then increased by 0.98% to 0.48 in 2022, then decreased by 7.6% to 0.44 in 2023, then decreased by 27.5% to 0.32 in 2024, then fell by 14.21% to 0.27 in 2025.
  • Its Asset Utilization Ratio stands at 0.27 for Q3 2025, versus 0.31 for Q2 2025 and 0.3 for Q1 2025.